Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
Intervalo de año de publicación
1.
J Control Release ; 107(2): 276-87, 2005 Oct 03.
Artículo en Inglés | MEDLINE | ID: mdl-16054724

RESUMEN

An analogous series of cationic lipids (1,2-distearyloxy-N,N-dimethyl-3-aminopropane (DSDMA), 1,2-dioleyloxy-N,N-dimethyl-3-aminopropane (DODMA), 1,2-dilinoleyloxy-N,N-dimethyl-3-aminopropane (DLinDMA) and 1,2-dilinolenyloxy-N,N-dimethyl-3-aminopropane (DLenDMA)) possessing 0, 1, 2 or 3 double bonds per alkyl chain respectively, was synthesized to determine the correlation between lipid saturation, fusogenicity and efficiency of intracellular nucleic acid delivery. 31P-NMR analysis suggests that as saturation increases, from 2 to 0 double bonds, lamellar (L(alpha)) to reversed hexagonal (H(II)) phase transition temperature increases, indicating decreasing fusogenicity. This trend is largely reflected by the efficiency of gene silencing observed in vitro when the lipids are formulated as Stable Nucleic Acid Lipid Particles (SNALPs) encapsulating small inhibitory RNA (siRNA). Uptake experiments suggest that despite their lower gene silencing efficiency, the less fusogenic particles are more readily internalized by cells. Microscopic visualization of fluorescently labelled siRNA uptake was supported by quantitative data acquired using radiolabelled preparations. Since electrostatic binding is a precursor to uptake, the pKa of each cationic lipid was determined. The results support a transfection model in which endosomal release, mediated by fusion with the endosomal membrane, results in cytoplasmic translocation of the nucleic acid payload.


Asunto(s)
Lípidos/química , ARN Interferente Pequeño/administración & dosificación , ARN Interferente Pequeño/química , Cationes , Línea Celular , Química Farmacéutica , Composición de Medicamentos , Sistemas de Liberación de Medicamentos , Expresión Génica/efectos de los fármacos , Silenciador del Gen , Humanos , Luciferasas/biosíntesis , Luciferasas/genética , Espectroscopía de Resonancia Magnética , Neuronas/efectos de los fármacos , ARN Interferente Pequeño/farmacología , Tolueno , Transfección
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA